FDA Clears Four-Plex Respiratory Test for COVID-19, Flu A/B and RSV
Sample-to-answer assay delivers results in approximately 45 minutes from nasopharyngeal and nasal swab specimens.
Read MorePosted by CLP Edit Staff | Nov 3, 2025 | Flu & Respiratory Infections |
Sample-to-answer assay delivers results in approximately 45 minutes from nasopharyngeal and nasal swab specimens.
Read MorePosted by CLP Edit Staff | Oct 30, 2025 | Compliance |
The pathologist served as joint plaintiff in successful lawsuit challenging FDA regulation of LDTs as medical devices.
Read MorePosted by CLP Edit Staff | Oct 29, 2025 | Molecular Diagnostics, Point-of-Care |
The collaboration will focus on creating a cortisol biosensor for stress and metabolic health testing using luminescent biosensors and AI-guided interpretation.
Read MorePosted by CLP Edit Staff | Oct 28, 2025 | Tuberculosis |
Single-button device designed to streamline workflow for PCR tuberculosis diagnostics in resource-limited settings, with potential deployment across India’s primary health centers.
Read MorePosted by CLP Edit Staff | Oct 27, 2025 | Sexually Transmitted Diseases |
Electrochemical biosensor aims to simultaneously detect HIV, Hepatitis B, and Hepatitis C in resource-limited settings using RNA-level identification.
Read More